These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1627 related items for PubMed ID: 19554337

  • 1. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A.
    Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
    [Abstract] [Full Text] [Related]

  • 3. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A.
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [Abstract] [Full Text] [Related]

  • 4. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D, Reuss D, Schittenhelm J, Hartmann C, Bremer J, Sahm F, Harter PN, Jeibmann A, von Deimling A.
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [Abstract] [Full Text] [Related]

  • 5. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C.
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [Abstract] [Full Text] [Related]

  • 6. Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience.
    Cho U, Yang SH, Yoo C.
    J Int Med Res; 2021 Jun; 49(6):3000605211019258. PubMed ID: 34162262
    [Abstract] [Full Text] [Related]

  • 7. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Seiz M, Tuettenberg J, Meyer J, Essig M, Schmieder K, Mawrin C, von Deimling A, Hartmann C.
    Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
    [Abstract] [Full Text] [Related]

  • 8. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
    Gravendeel LA, Kloosterhof NK, Bralten LB, van Marion R, Dubbink HJ, Dinjens W, Bleeker FE, Hoogenraad CC, Michiels E, Kros JM, van den Bent M, Smitt PA, French PJ.
    Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
    [Abstract] [Full Text] [Related]

  • 9. IDH1 and IDH2 mutations in gliomas.
    Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD.
    N Engl J Med; 2009 Feb 19; 360(8):765-73. PubMed ID: 19228619
    [Abstract] [Full Text] [Related]

  • 10. Analysis of IDH1 and IDH2 mutations in Japanese glioma patients.
    Sonoda Y, Kumabe T, Nakamura T, Saito R, Kanamori M, Yamashita Y, Suzuki H, Tominaga T.
    Cancer Sci; 2009 Oct 19; 100(10):1996-8. PubMed ID: 19765000
    [Abstract] [Full Text] [Related]

  • 11. Glioma-derived mutations in IDH: from mechanism to potential therapy.
    Fu Y, Huang R, Du J, Yang R, An N, Liang A.
    Biochem Biophys Res Commun; 2010 Jun 25; 397(2):127-30. PubMed ID: 20510884
    [Abstract] [Full Text] [Related]

  • 12. IDH mutations in glioma and acute myeloid leukemia.
    Dang L, Jin S, Su SM.
    Trends Mol Med; 2010 Sep 25; 16(9):387-97. PubMed ID: 20692206
    [Abstract] [Full Text] [Related]

  • 13. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.
    Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, Frattini M, Molinari F, Knowles M, Cerrato A, Rodolfo M, Scarpa A, Felicioni L, Buttitta F, Malatesta S, Marchetti A, Bardelli A.
    Hum Mutat; 2009 Jan 25; 30(1):7-11. PubMed ID: 19117336
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
    Ducray F, Mokhtari K, Crinière E, Idbaih A, Marie Y, Dehais C, Paris S, Carpentier C, Dieme MJ, Adam C, Hoang-Xuan K, Duyckaerts C, Delattre JY, Sanson M.
    Eur J Cancer; 2011 Mar 25; 47(5):802-8. PubMed ID: 21194923
    [Abstract] [Full Text] [Related]

  • 15. Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas.
    Murugan AK, Alzahrani AS.
    Br J Biomed Sci; 2022 Mar 25; 79():10208. PubMed ID: 35996504
    [Abstract] [Full Text] [Related]

  • 16. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
    Watanabe T, Vital A, Nobusawa S, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2009 Jun 25; 117(6):653-6. PubMed ID: 19340432
    [Abstract] [Full Text] [Related]

  • 17. IDH1 and IDH2 mutations in gliomas.
    Ducray F, Marie Y, Sanson M.
    N Engl J Med; 2009 May 21; 360(21):2248-9; author reply 2249. PubMed ID: 19469031
    [No Abstract] [Full Text] [Related]

  • 18. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
    Thota B, Shukla SK, Srividya MR, Shwetha SD, Arivazhagan A, Thennarasu K, Chickabasaviah YT, Hegde AS, Chandramouli BA, Somasundaram K, Santosh V.
    Am J Clin Pathol; 2012 Aug 21; 138(2):177-84. PubMed ID: 22904127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.